Variant report

Variant	esv3361465
Chromosome Location	chr12:42982310-42984858
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr12:42982800-42983141	H1-hESC	embryonic stem cell:	n/a	n/a
2	BACH1	chr12:42983611-42983906	H1-hESC	embryonic stem cell:	n/a	n/a
3	BACH1	chr12:42984246-42984643	H1-hESC	embryonic stem cell:	n/a	n/a
4	BCLAF1	chr12:42983564-42983826	GM12878	blood:	n/a	chr12:42983763-42983776
5	CCNT2	chr12:42983171-42983827	K562	blood:	n/a	n/a
6	CHD1	chr12:42983449-42983494	H1-hESC	embryonic stem cell:	n/a	n/a
7	CHD2	chr12:42983639-42983711	H1-hESC	embryonic stem cell:	n/a	n/a
8	CREB1	chr12:42983333-42983795	A549	lung:	n/a	n/a
9	CTBP2	chr12:42982768-42984725	H1-hESC	embryonic stem cell:	n/a	n/a
10	CTCF	chr12:42982780-42982930	HRPEpiC	eye:	n/a	chr12:42982868-42982889
11	CTCF	chr12:42984500-42984650	HCPEpiC	choroid plexus:	n/a	chr12:42984591-42984609
12	CTCF	chr12:42984480-42984630	HBMEC	blood vessel:	n/a	chr12:42984591-42984609
13	CTCF	chr12:42982758-42983008	GM19240	blood:	n/a	chr12:42982868-42982889
14	CTCF	chr12:42982698-42983051	GM12878	blood:	n/a	chr12:42982868-42982889
15	CTCF	chr12:42984511-42984686	MCF-7	breast:	n/a	chr12:42984591-42984609
16	CTCF	chr12:42982800-42982950	HRPEpiC	eye:	n/a	chr12:42982868-42982889
17	CTCF	chr12:42982783-42982990	HepG2	liver:	n/a	chr12:42982868-42982889
18	CTCF	chr12:42982781-42982989	GM12878	blood:	n/a	chr12:42982868-42982889
19	CTCF	chr12:42984380-42984530	BE2_C	brain:	n/a	n/a
20	CTCF	chr12:42982800-42982950	HPF	lung:	n/a	chr12:42982868-42982889
21	CTCF	chr12:42984543-42984546	ProgFib	skin:	n/a	n/a
22	CTCF	chr12:42982800-42982950	AG10803	skin:	n/a	chr12:42982868-42982889
23	CTCF	chr12:42984522-42984677	MCF-7	breast:	n/a	chr12:42984591-42984609
24	CTCF	chr12:42982800-42982950	HL-60	blood:	n/a	chr12:42982868-42982889
25	CTCF	chr12:42982740-42983016	H1-hESC	embryonic stem cell:	n/a	chr12:42982868-42982889
26	CTCF	chr12:42982820-42982970	GM12870	blood:	n/a	chr12:42982868-42982889
27	CTCF	chr12:42982760-42982910	GM12865	blood:	n/a	chr12:42982868-42982889
28	CTCF	chr12:42984512-42984684	H1-hESC	embryonic stem cell:	n/a	chr12:42984591-42984609
29	CTCF	chr12:42984480-42984630	HPF	lung:	n/a	chr12:42984591-42984609
30	CTCF	chr12:42984440-42984590	HA-sp	spinal cord:	n/a	n/a
31	CTCF	chr12:42982800-42982950	HEEpiC	esophagus:	n/a	chr12:42982868-42982889
32	CTCF	chr12:42982786-42982964	GM12892	blood:	n/a	chr12:42982868-42982889
33	CTCF	chr12:42982763-42983060	K562	blood:	n/a	chr12:42982868-42982889
34	CTCF	chr12:42982820-42982970	HA-sp	spinal cord:	n/a	chr12:42982868-42982889
35	CTCF	chr12:42982800-42982950	HEK293	kidney:	n/a	chr12:42982868-42982889
36	CTCF	chr12:42984548-42984622	GM13977	blood:	n/a	chr12:42984591-42984609
37	CTCF	chr12:42984460-42984610	SAEC	small airway:	n/a	chr12:42984591-42984609
38	CTCF	chr12:42982781-42982969	SK-N-SH_RA	brain:	n/a	chr12:42982868-42982889
39	CTCF	chr12:42982789-42982958	GM10266	blood:	n/a	chr12:42982868-42982889
40	CTCF	chr12:42982840-42982990	HEK293	kidney:	n/a	chr12:42982868-42982889
41	CTCF	chr12:42984420-42984570	HFF-Myc	foreskin:	n/a	n/a
42	CTCF	chr12:42982781-42982968	ProgFib	skin:	n/a	chr12:42982868-42982889
43	CTCF	chr12:42982800-42982950	HUVEC	blood vessel:	n/a	chr12:42982868-42982889
44	CTCF	chr12:42984440-42984590	AG04449	skin:	n/a	n/a
45	CTCF	chr12:42982800-42982950	GM12874	blood:	n/a	chr12:42982868-42982889
46	CTCF	chr12:42982790-42982964	A549	lung:	n/a	chr12:42982868-42982889
47	CTCF	chr12:42982719-42983027	T-47D	breast:	n/a	chr12:42982868-42982889
48	CTCF	chr12:42982860-42983010	HAc	cerebellar:	n/a	chr12:42982868-42982889
49	CTCF	chr12:42982780-42982930	AG10803	skin:	n/a	chr12:42982868-42982889
50	CTCF	chr12:42984500-42984650	HPF	lung:	n/a	chr12:42984591-42984609

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:42982419-42982469	Hepatocyte	liver:	n/a
2	chr12:42984224-42984274	HL-60	blood:	n/a
3	chr12:42982419-42982469	Hepatocyte	liver:	n/a
4	chr12:42984224-42984274	HL-60	blood:	n/a
5	chr12:42982929-42982979	ECC-1	luminal epithelium:	n/a
6	chr12:42983805-42983855	HNPCEpiC	eye:	n/a
7	chr12:42983805-42983855	ProgFib	skin:	n/a
8	chr12:42982649-42982699	HUVEC	blood vessel:	n/a
9	chr12:42982929-42982979	HCF	heart:	n/a
10	chr12:42984236-42984286	RPTEC	kidney:	n/a
11	chr12:42983805-42983855	AG04449	skin:	fetal
12	chr12:42984114-42984164	T-47D	breast:	n/a
13	chr12:42984337-42984387	HCPEpiC	choroid plexus:	n/a
14	chr12:42983360-42983410	HAEpiC	amniotic membrane:	n/a
15	chr12:42984224-42984274	ProgFib	skin:	n/a
16	chr12:42983805-42983855	SKMC	muscle:	n/a
17	chr12:42982419-42982469	NHBE	bronchial:	n/a
18	chr12:42982419-42982469	GM06990	blood:	n/a
19	chr12:42984236-42984286	HNPCEpiC	eye:	n/a
20	chr12:42984114-42984164	LNCaP	prostate:	n/a
21	chr12:42984093-42984143	SKMC	muscle:	n/a
22	chr12:42984224-42984274	Caco-2	colon:	n/a
23	chr12:42983805-42983855	SK-N-MC	brain:	n/a
24	chr12:42984466-42984516	NT2-D1	testis:	n/a
25	chr12:42984093-42984143	PANC-1	pancreas:	n/a
26	chr12:42984466-42984516	HPAEpiC	pulmonary alveolar:	n/a
27	chr12:42984337-42984387	MCF-7	breast:	n/a
28	chr12:42984093-42984143	HAEpiC	amniotic membrane:	n/a
29	chr12:42982649-42982699	HIPEpiC	eye:	n/a
30	chr12:42984337-42984387	GM06990	blood:	n/a
31	chr12:42984224-42984274	T-47D	breast:	n/a
32	chr12:42982929-42982979	HL-60	blood:	n/a
33	chr12:42982649-42982699	HAEpiC	amniotic membrane:	n/a
34	chr12:42983360-42983410	HCF	heart:	n/a
35	chr12:42984466-42984516	AG09309	skin:	n/a
36	chr12:42984224-42984274	K562	blood:	n/a
37	chr12:42982649-42982699	AG10803	skin:	n/a
38	chr12:42984093-42984143	SAEC	small airway:	n/a
39	chr12:42984114-42984164	SK-N-SH	brain:	n/a
40	chr12:42984236-42984286	BE2_C	brain:	n/a
41	chr12:42983360-42983410	AG10803	skin:	n/a
42	chr12:42983805-42983855	LNCaP	prostate:	n/a
43	chr12:42984093-42984143	Jurkat	blood:	n/a
44	chr12:42984337-42984387	GM12891	blood:	n/a
45	chr12:42984114-42984164	SAEC	small airway:	n/a
46	chr12:42984337-42984387	AG09319	gingival:	n/a
47	chr12:42983360-42983410	HCM	heart:	n/a
48	chr12:42982649-42982699	HPAEpiC	pulmonary alveolar:	n/a
49	chr12:42983805-42983855	HCPEpiC	choroid plexus:	n/a
50	chr12:42984337-42984387	NHBE	bronchial:	n/a

No.	Distal block	Cell Line	Cell type
1	chr12:42984197..42984716-chr12:43676086..43676642,2	MCF-7	breast:
2	chr12:42982454..42982981-chr12:43675696..43676627,2	MCF-7	breast:
3	chr12:42975394..42979509-chr12:42980340..42982880,4	K562	blood:
4	chr12:42982698..42983359-chr12:43198437..43199068,2	MCF-7	breast:
5	chr12:42982822..42983322-chr12:43730434..43730991,2	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ZCRB1-2	chr12:42983267-42983546	NONHSAT027781

Variant related genes	Relation type
PRICKLE1	TF binding region
PRICKLE1	CpG island

Extended variants
information (count: 69 )
Associated
traits (count: 58 )

Variant overlapped rSNPs/rCNVs (count:69 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs570978409	chr12:42982327-42982328	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs538483894	chr12:42982366-42982367	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs4768423	chr12:42982369-42982370	Bivalent/Poised TSS Bivalent Enhancer Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs181674858	chr12:42982442-42982443	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs541404315	chr12:42982486-42982487	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs547205257	chr12:42982491-42982492	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs185619733	chr12:42982502-42982503	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs571776424	chr12:42982508-42982509	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs545604382	chr12:42982526-42982527	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs564261134	chr12:42982650-42982651	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs531413868	chr12:42982653-42982654	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs118143582	chr12:42982661-42982662	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs190383510	chr12:42982763-42982764	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs74362389	chr12:42982801-42982802	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs182546608	chr12:42982884-42982885	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs548587005	chr12:42982904-42982905	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs373100898	chr12:42982907-42982908	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs566887415	chr12:42983027-42983028	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
19	rs144868398	chr12:42983069-42983070	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
20	rs188063876	chr12:42983081-42983082	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
21	rs552392019	chr12:42983098-42983099	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
22	rs75377998	chr12:42983135-42983136	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
23	rs2141929	chr12:42983138-42983139	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs79374882	chr12:42983159-42983160	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
25	rs556367191	chr12:42983160-42983161	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
26	rs568399443	chr12:42983248-42983249	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs561368128	chr12:42983324-42983325	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
28	rs545930952	chr12:42983341-42983342	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
29	rs117521428	chr12:42983399-42983400	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Flanking Active TSS Transcr. at gene 5' and 3' Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
30	rs145508056	chr12:42983408-42983409	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
31	rs548377394	chr12:42983422-42983423	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
32	rs557557453	chr12:42983431-42983432	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
33	rs576131579	chr12:42983434-42983435	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
34	rs543617300	chr12:42983467-42983468	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
35	rs561895960	chr12:42983542-42983543	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
36	rs573947148	chr12:42983607-42983608	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs11837158	chr12:42983762-42983763	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs536986417	chr12:42983767-42983768	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs370260611	chr12:42983780-42983781	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs190800488	chr12:42983795-42983796	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs112357144	chr12:42983812-42983813	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
42	rs5797813	chr12:42983891-42983892	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs560478560	chr12:42983926-42983927	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs527693850	chr12:42983931-42983932	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs183902352	chr12:42983949-42983950	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs564403108	chr12:42983991-42983992	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs74818946	chr12:42983995-42983996	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs549929214	chr12:42984059-42984060	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs568340682	chr12:42984075-42984076	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs140035748	chr12:42984088-42984089	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:58)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Seminomas	18059402	CNVD
Wilms tumour	21544195	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Ewing''s sarcoma	21437220	CNVD
Testicular germ cell tumor	18059402	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Ewing''s sarcoma	17952124	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Neurodevelopmental disorder	22521361	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	21949216	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Acute myeloid leukemia	16864856	CNVD
Cancer	21637783	CNVD
Glioblastoma multiforme	21080181	CNVD
Renal cell carcinoma	19461508	CNVD
Burkitt''s lymphoma	18698080	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Gastrointestinal stromal cancer	20470368	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	17603634	CNVD
Cancer	21183584	CNVD
Hirschsprung''s Disease	21712996	CNVD
Lissencephaly	21572526	CNVD
Lung cancer	18438408	CNVD
Acute myeloid leukemia	21251322	CNVD
small cell lung cancer	20016488	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Breast cancer	19602461	CNVD
Breast cancer	17899364	CNVD
Colorectal cancer	16272173	CNVD
Breast cancer	21364760	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD

Chromatin state (count:441 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:42979800-42982400	Weak transcription	Psoas Muscle	Psoas
2	chr12:42980000-42985000	Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
3	chr12:42980600-42984200	Active TSS	HSMMtube	muscle
4	chr12:42980800-42982600	Flanking Active TSS	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
5	chr12:42980800-42984200	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
6	chr12:42981000-42984000	Active TSS	Brain Angular Gyrus	brain
7	chr12:42981000-42984000	Active TSS	Fetal Muscle Leg	muscle
8	chr12:42981200-42982400	Flanking Active TSS	Stomach Smooth Muscle	stomach
9	chr12:42981200-42982600	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
10	chr12:42981200-42983000	Active TSS	Brain Inferior Temporal Lobe	brain
11	chr12:42981200-42983800	Bivalent/Poised TSS	Brain Cingulate Gyrus	brain
12	chr12:42981200-42984000	Active TSS	IMR90 fetal lung fibroblasts Cell Line	lung
13	chr12:42981200-42985000	Active TSS	Right Atrium	heart
14	chr12:42981400-42982400	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
15	chr12:42981400-42982400	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
16	chr12:42981400-42982400	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
17	chr12:42981400-42982400	Bivalent Enhancer	Primary monocytes fromperipheralblood	blood
18	chr12:42981400-42982400	Enhancers	Stomach Mucosa	stomach
19	chr12:42981400-42982600	Flanking Active TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
20	chr12:42981400-42982600	Flanking Active TSS	NHEK	skin
21	chr12:42981400-42984000	Active TSS	H1 Derived Mesenchymal Stem Cells	ES cell derived
22	chr12:42981400-42984000	Bivalent/Poised TSS	Brain Hippocampus Middle	brain
23	chr12:42981400-42984200	Active TSS	Brain Anterior Caudate	brain
24	chr12:42981400-42984800	Active TSS	Right Ventricle	heart
25	chr12:42981600-42982400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
26	chr12:42981600-42982400	Bivalent/Poised TSS	Fetal Adrenal Gland	Adrenal Gland
27	chr12:42981600-42982400	Weak transcription	Lung	lung
28	chr12:42981600-42982800	Active TSS	Foreskin Fibroblast Primary Cells skin02	Skin
29	chr12:42981600-42982800	Active TSS	Fetal Muscle Trunk	muscle
30	chr12:42981600-42982800	Active TSS	Fetal Stomach	stomach
31	chr12:42981600-42983000	Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
32	chr12:42981600-42983200	Flanking Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
33	chr12:42981600-42983200	Active TSS	Fetal Heart	heart
34	chr12:42981600-42983200	Flanking Active TSS	Skeletal Muscle Female	skeletal muscle
35	chr12:42981600-42984200	Active TSS	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
36	chr12:42981600-42984400	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
37	chr12:42981600-42985000	Active TSS	Fetal Kidney	kidney
38	chr12:42981800-42982400	Flanking Active TSS	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
39	chr12:42981800-42982400	Enhancers	Pancreas	Pancrea
40	chr12:42981800-42982400	Enhancers	Placenta Amnion	Placenta Amnion
41	chr12:42981800-42982400	Enhancers	Spleen	Spleen
42	chr12:42981800-42982600	Flanking Active TSS	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
43	chr12:42981800-42982600	Flanking Bivalent TSS/Enh	NHDF-Ad	bronchial
44	chr12:42981800-42982800	Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
45	chr12:42981800-42982800	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin03	Skin
46	chr12:42981800-42983200	Flanking Bivalent TSS/Enh	Fetal Intestine Large	intestine
47	chr12:42981800-42983200	Flanking Bivalent TSS/Enh	Fetal Intestine Small	intestine
48	chr12:42981800-42983200	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
49	chr12:42981800-42984600	Bivalent/Poised TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
50	chr12:42981800-42984800	Bivalent/Poised TSS	Rectal Mucosa Donor 29	rectum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links